Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child.

Abstract excerpt

Isolated endobronchial inflammatory myofibroblastic tumors (IMT) are rare, accounting for about 1% of primary endobronchial tumors in children. The mainstay of treatment for this tumor has been surgical resection. Recently, the identification of anaplastic lymphoma kinase (ALK) gene mutations in half of IMTs and promising results of treatment with ALK inhibitors in other ALK-positive tumors have opened the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child, Preschool
• Share to Crizotinib
• Share to Mutation